Difference between revisions of "Profiles"

From QIBA Wiki
Jump to navigation Jump to search
m
Line 32: Line 32:
  
 
*[[Media:QIBA DSC-MRI Stage2-Consensus Profile.pdf| MR Dynamic Contrast Susceptibility (DSC) 2020-10-22]]
 
*[[Media:QIBA DSC-MRI Stage2-Consensus Profile.pdf| MR Dynamic Contrast Susceptibility (DSC) 2020-10-22]]
 
*[[Media:MRE-QIBAProfile-2018-05-02-CONSENSUS.pdf| MR Elastography of the Liver 2018-05-02]]
 
  
 
*[[Media:QIBA Profile MSK-Cartilage-Stage2 Profile.pdf| MR MSK cartilage for joint disease 2021-09-25]]
 
*[[Media:QIBA Profile MSK-Cartilage-Stage2 Profile.pdf| MR MSK cartilage for joint disease 2021-09-25]]

Revision as of 15:35, 31 August 2022

Profiles published here have completed one of the QIBA Profile Stages of development and been approved by their Biomarker Committee.

Profiles may be of use at any Stage.

Stage 3: Clinically Feasible (formerly Technically Confirmed) Profiles

  • 32 pages including Conformance Checklists

Stage 2: Consensus Profiles

Stage 1: Public Comment Profiles

Please submit comments using the online form


Comment Resolutions are posted for Past Public Comments and Past Technical Confirmations.


Format for Citing Profiles

Cite QIBA Profile documents as:

Specific QIBA Biomarker Committee. Specific Profile Title, Quantitative Imaging Biomarkers Alliance. Version. Profile Stage. Date. Available from: URL

Example:

QIBA MR Biomarker Committee. MR Elastography of the Liver, Quantitative Imaging Biomarkers Alliance. Profile Stage: Consensus. June 6, 2019. Available from: http://qibawiki.rsna.org/index.php/Profiles


Statements of Endorsement


See Also